@fadaa thank you for posting as I had not seen this. The results have been posted on clinicaltrial.gov/ for a while, but this is the 1st written review of the data. This was a study where the main component being tested was the dc vaccine. There were a number of issues in harvesting sufficient tumor cells to create the vaccine and patient recruitment was also a bit dicey. What is interesting is the comment I included in the snapshot below which mentions the CRC Liver Mets study and that it is currently undergoing analysis. This is the study combining celebrex, interferon and ampligen I posted about last night. Be on the lookout for this data. As it relates to this study, the effectiveness or lack effectiveness of Ampligen cant be concluded.
  • 3
3 Likes